Calculate Your Salary Ranking
Home > Acorda Therapeutics Salary

Acorda Therapeutics Salary
  • 92
  • 92
  • 94

Acorda Therapeutics average salary is $95,301, median salary is $85,540 with a salary range from $36,000 to $215,405.
Acorda Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Acorda Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
36,000
Average
95,301
Median
85,540
High
215,405
Total 14 Acorda Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
General 82,139-177,403 Ardsley, NY, 10502 2015 Acorda Therapeutics General Salaries (4)
Acorda Therapeutics Ardsley, NY Salaries
General 215,405-215,405 Hawthorne, NY, 10532 2015 Acorda Therapeutics General Salaries (4)
Acorda Therapeutics Hawthorne, NY Salaries
Scientist 88,941-88,941 Hawthorne, NY, 10532 2015 Acorda Therapeutics Scientist Salaries (1)
Acorda Therapeutics Hawthorne, NY Salaries
General 155,900-155,900 Ardsley, NY, 10502 2014 Acorda Therapeutics General Salaries (4)
Acorda Therapeutics Ardsley, NY Salaries
Regulatory Submissions Manager 121,500-121,500 Ardsley, NY, 10502 2012 Acorda Therapeutics Regulatory Submissions Manager Salaries (4)
Acorda Therapeutics Ardsley, NY Salaries
Biostatistician I 60,300-60,800 Hawthorne, NY, 10532 2011 Acorda Therapeutics Biostatistician I Salaries (2)
Acorda Therapeutics Hawthorne, NY Salaries
Manager Educational Services, Sr. Educational Serv 112,530-116,200 Hawthorne, NY, 10532 2011 Acorda Therapeutics Manager Educational Services, Sr. Educational Serv Salaries (2)
Acorda Therapeutics Hawthorne, NY Salaries
Regulatory Submissions Manager 90,000-97,500 Hawthorne, NY, 10532 2010 Acorda Therapeutics Regulatory Submissions Manager Salaries (4)
Acorda Therapeutics Hawthorne, NY Salaries
Writer 75,000-75,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics Writer Salaries (3)
Acorda Therapeutics Hawthorne, NY Salaries
Scientist I 62,000-70,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics Scientist I Salaries (2)
Acorda Therapeutics Hawthorne, NY Salaries
All Other, Managers 115,000-115,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics All Other, Managers Salaries (1)
Acorda Therapeutics Hawthorne, NY Salaries
Post-Doctoral Fellow 50,000-50,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics Post-Doctoral Fellow Salaries (1)
Acorda Therapeutics Hawthorne, NY Salaries
Research Associate 36,000-36,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics Research Associate Salaries (1)
Acorda Therapeutics Hawthorne, NY Salaries
Research Scientist 70,000-70,000 Hawthorne, NY, 10532 2010 Acorda Therapeutics Research Scientist Salaries (1)
Acorda Therapeutics Hawthorne, NY Salaries
1
Acorda Therapeutics Jobs
See more Acorda The Jobs »
  • Manufacturing Associate - Nights
    Acorda Therapeutics Summary : The Manufacturing Associate performs routine and complex operations for the GMP production of pharmaceutical products. This
  • Biostatistician II Temp
    Summary: The Biostatistician II temp is responsible for developing, modifying and evaluating statistical elements of clinical trials and basic research. In
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Acorda Therapeutics Salaries (August 25, 2016)
General Acorda Therapeutics $215,405 Hawthorne, NY, 10532 08/06/2015
General Acorda Therapeutics $82,139 Ardsley, NY, 10502 09/12/2015

Acorda Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Acorda Therapeutics Information
  • Acorda Therapeutics
  • Industry: BioTech/Drugs
  • City: Hawthorne, NY
  • Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI) and related neurological conditions, including multiple sclerosis (MS). The Company's lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and Phase 2 for MS. Acorda's technology platform includes two remyelinating agents in preclinical development for MS. They include M1, a class of human monoclonal antibodies, and GGF2, a product of the neuregulin 1 gene. Both agents have been shown to restore myelin in the brain and spinal cord in animal models of MS. Additionally, Acorda is developing multiple approaches to regeneration and